Jones Lang LaSalle Inc. (0JPB)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 302.51 |
|---|---|
| 52-week range | 259.67 – 397.24 |
| Return, 1 month / 3 months | −9.4% / −8.6% |
| Return, 1 year / 3 years | +2.4% / +129.2% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 38.2% |
| Worst drawdown (1 year) | -25.6% |
| Average daily value traded | 0.04M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jones Lang LaSalle is a commercial real estate services firm based in Chicago. It advises owners and occupiers of property on leasing, property management, investment sales and corporate real estate needs. Its clients include investors, developers, corporations and public institutions, and it operates through offices in many countries around the world. The firm also provides research and advisory services connected to commercial property markets.
On this site Jones Lang LaSalle Inc. appears as a stock on the London Exchange (UK), code 0JPB, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jones Lang LaSalle Inc. (0JPB) trades on the London Exchange in UK. It last closed at USD 302.51 on 19 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,496 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.4% and over the last three months it fell 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.2% | ||
| From 52-week high | -22.4% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.6% | ||
| 6-month return | -13.1% | ||
| 12-month return, skipping the last month | 13.0% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.6% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −9.4% |
| 3 months | −8.6% |
| 6 months | −13.1% |
| 1 year | +2.4% |
| 3 years | +129.2% |
| 5 years | +19.7% |
Signals
| 50-day / 200-day average | 342.47 / 326.06 |
|---|---|
| Golden / death cross (60 days) | Golden, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Nov 2019 | USD 0.4300 |
| 16 May 2019 | USD 0.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.